Flavocure Biotech, Inc. Announces a New Appointment to the Advisory Board

“Baltimore, Maryland–(Newsfile Corp. – June 7, 2021) – The Board and Management of Flavocure Biotech, Inc. (“Flavocure”) a drug discovery and development company, announced today the appointment of Dr Thomas F. Woolf, PhD, an expert in pharmaceutical sciences to the company’s Board of Advisors.”

“Flavocure is a clinical stage ready company, and its first drug candidate targets pancreatic adenocarcinoma which is currently uncurable.”

To read more:


Leave a Reply

Your email address will not be published. Required fields are marked *